A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
US FDA Approves Generic Bromfenac Drops from India’s Lupin for Postsurgical Pain and Inflammation
Author: Jennie Crabbe
Indian drugmaker Lupin announced Aug. 16 that the US FDA had approved its abbreviated new drug application for bromfenac ophthalmic solution, 0.09%, a generic equivalent of Bausch + Lomb’s Bromday.
Bromfenac is a nonsteroidal anti-inflammatory eye drop used to decrease inflammation and relieve pain after cataract surgery.
Lupin, with 12 locations worldwide, said the product would be manufactured at its facility in Pithampur, India.